H5N1 Outbreaks, Predicted One Year Ago by BioRadar(TM), Now Appear in 63 Countries; TransFlu(TM) Vaccine Shown Effective Against H5N1 in Chickens

LONDON, April 9 /PRNewswire/ -- The most recent BioRadar™ (FluForecast™) analysis of the virus genomes of both H5N1, known for high lethality, and H1N1, known for high infectivity, indicates that the Replikin Counts™ of both strains are rising. Such Count increases in a specific strain have been invariably associated with clinical outbreaks of that strain. The H1N1 outbreak in 2009 was predicted one year in advance by BioRadar™ software (replikins.com, Replikins Press, 2008). Previous H5N1 outbreaks, and their location (Indonesia), were correctly predicted, and most recently, the current H5N1 outbreak was similarly predicted one year in advance by BioRadar™ software (replikins.com, Replikins Press, January 15, 2010).

This new data will be presented at the forthcoming scientific workshop on the "Replikins BioRadar™ Surveillance System" on April 30th, sponsored by UK Trade and Investment, to take place at 1 Victoria Street, London. Scientists from public health institutions in the U.S., U.K., Denmark and France -- initial participants in the BioRadar™ surveillance network -- will attend (http://www.newsroom.uktradeinvest.gov.uk/news.ashx).

Past pandemics have seen the predominance of only one influenza strain. The H1N1 virus Replikin Count, as of April 7, 2010, has not returned to pre-outbreak levels, but in fact is rising. At the same time, the H5N1 virus Replikin Count continues to rise in a third cycle, as predicted by H9N2-H5N1 data one year ago (replikins.com, Replikins Press, January 15, 2009), and now realized in new outbreaks of H5N1 reported in 63 countries (CIDRAP, March 23, 2010), with 22 human cases, 8 fatal this year (WHO, March 30, 2010). Egypt has reported 16 human cases, of which 5 have been fatal (CIDRAP, March 15, 2010). Vietnam has had 2 lethalities (Reuters, March 18, 2010).

Replikins, Ltd. has produced a Synthetic Replikins Vaccine, TransFlu™, with elements against both H5N1 and H1N1. In an independent trial, TransFlu™ vaccine has blocked H5N1 in chickens (doi: Avian Diseases 10.637/8892-042509-ResNote.1). This is one example of the function of the BioRadar™ system of "Early Detection->Rapid Response." Formulation of the TransFlu™ vaccine began over one year ago, based on H5N1 Replikins Analysis, when the increase in H5N1 virus Replikin Count predicted the present H5N1 outbreaks.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE Replikins, Ltd.

Back to top